Skip to main content

Closed

ORMP: Oramed Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-4.6%

Financially safe

Strong

Debt / equity0.00×

Interest coverage42.3×

Current ratio6.45×

Valuation

Unrated

P/E ratio1.5×

Dividend yield6.1%

Oramed Pharmaceuticals Inc.

ORMPNASDAQ Capital Market·USD·Closed

Oramed Pharmaceuticals Inc.

ORMPNASDAQ·USD·Closed

$4.07

−1.21%

$4.07

−$0.05 (1.21%)

52W Range

65thpctl

Volume

0.70×avg

Mkt Cap

166.57MUSD

P/E

1.5TTM

Div Yield

6.14%ann

52W Range

65thpctl

Volume

0.70×avg

Market Cap

166.57MUSD

P/E Ratio

1.5TTM

Div Yield

6.14%ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings